Websites with info on Clinical Trials - Conventional and Alternative

For details on some of the Complementary And Alternative Medicine Clinical Trials
For Cancer Treatment, go to http://cpmcnet.columbia.edu/dept/rosenthal/cancer/info/ctrials.html. These include: Burzynski's Clinical Trials on antineoplastins, Dr. Gonzales's trials for pancreatic cancer, and Dr. Simones' trials of shark cartilage and lifestyle modifications for other cancers.

The following sites are mostly conventional, but there are some cases in which alternative approaches are being tested.

http://www.cancerguide.org/internet_trials.html  
http://www.acurian.com/diseases/disease_ct.jsp?ta=ONC http://www.acurian.com/diseases/disease_ct.jsp?ta=ONC http://cpmcnet.columbia.edu/dept/rosenthal/cancer/info/ctrials.html

For a list of foreign trials, go to: http://www.foreigntrials.com/trials_list.html - there are several clinical trials using mistletoe.

Clinical trials are underway on St157, a cancer pill that seems to have good results when treating chronic myelogenous leukemia (CML). It may also be effective in treating certain types of brain and stomach cancers. Go to http://cancertrials.nci.nih.gov/types/leuk/sti571/.

Volunteers Sought for Vitamin E, Selenium Study In Largest-Ever Prostate Cancer Trial

Health locations across the United States, Puerto Rico and Canada are putting out calls for male volunteers to take part in what is termed "the largest prostate cancer prevention trial that's ever been performed," a study of the roles of Vitamin E and selenium as antioxidants that help control cell damage leading to prostate cancer. 

The study is being conducted by the National Cancer Institute, part of the National Institutes of Health (NIH) in Bethesda, Md. It is called SELECT, for "Selenium and Vitamin E Cancer Prevention Trial." Previous studies have shown that natural Vitamin E can reduce prostate cancer by as much as 32 percent, and selenium, in its natural mineral form, has also been demonstrated to reduce prostate cancer in male participants.

Some 400 U.S. locations are recruiting 32,400 men for the 12-year study. Go to http://cancertrials.nci.nih.gov/types/prostate/select/ for information on this. Those who are interested in the possibility of joining the SELECT trial should contact the NCI's Cancer Information Service at 1-800-4CANCER (1-800-422-6237) or TTY: 1-800-332-8615. In Canada, call the Canadian Cancer Society's Cancer Information Service at 1-888-939-3333. To be eligible for the SELECT trial, participants must have a DRE that indicates no signs of prostate cancer and a total PSA level less than or equal to 4.0 ng/ml.

There are several Patient's Bills of Rights before the senate and house - HR 2563 would mandate that insurance companies cover the cost of clinical trials. For more information, go to http://olpa.od.nih.gov/Legislation.  Although no legislation gives all Americans the option to participate in clinical trials, a National Coverage Decision became effective on September 19, 2000, and now requires Medicare to pay for the routine costs of a qualified clinical trial.